1,125
Views
0
CrossRef citations to date
0
Altmetric
Research Article

CircPLXNB2 regulates acute myeloid leukemia progression through miR-654-3p/CCND1 axis

, &
Article: 2220522 | Received 04 Dec 2022, Accepted 29 May 2023, Published online: 05 Jun 2023

References

  • Gregory TK, Wald D, Chen Y, et al. Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. J Hematol Oncol. 2009;2:23. DOI:10.1186/1756-8722-2-23
  • Shih AH, Abdel-Wahab O, Patel JP, et al. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012;12(9):599–612. DOI:10.1038/nrc3343
  • De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6(7):e441. DOI:10.1038/bcj.2016.50
  • Crossnohere NL, Richardson DR, Reinhart C, et al. Side effects from acute myeloid leukemia treatment: results from a national survey. Curr Med Res Opin. 2019;35(11):1965–1970. DOI:10.1080/03007995.2019.1631149
  • Short NJ, Konopleva M, Kadia TM, et al. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges. Cancer Discov. 2020;10(4):506–525. DOI:10.1158/2159-8290.CD-19-1011
  • Owattanapanich W, Herzig J, Jahn N, et al. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique. Ann Hematol 2021;100(8):1983–1993.
  • Mehdipour P, Santoro F, Minucci S. Epigenetic alterations in acute myeloid leukemias. FEBS J 2015;282(9):1786–1800.
  • Lux S, Blätte TJ, Gillissen B, et al. Deregulated expression of circular RNAs in acute myeloid leukemia. Blood Adv. 2021;5(5):1490–1503.
  • Vo JN, Cieslik M, Zhang Y, et al. The landscape of circular RNA in cancer. Cell. 2019;176(4):869–881.e13. DOI:10.1016/j.cell.2018.12.021
  • Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6. DOI:10.1186/s12943-018-0934-6
  • Yan B, Zhang Y, Liang C, et al. Stem cell-derived exosomes prevent pyroptosis and repair ischemic muscle injury through a novel exosome/circHIPK3/ FOXO3a pathway. Theranostics. 2020;10(15):6728–6742.
  • Awan FM, Yang BB, Naz A, et al. The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents. RNA Biol. 2021;18(1):1–15.
  • Shah MY, Ferrajoli A, Sood AK, et al. Microrna therapeutics in cancer – an emerging concept. EBioMedicine. 2016;12:34–42. DOI:10.1016/j.ebiom.2016.09.017
  • Wang J, Li H, Liang Z. circ-MYBL2 Serves As A Sponge For miR-361-3p Promoting Cervical Cancer Cells Proliferation And Invasion. Onco Targets Ther. 2019;12:9957–9964. DOI:10.2147/OTT.S218976
  • Li X, Yang B, Ren H, et al. Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p. Cell Death Dis. 2019;10(12):953. DOI:10.1038/s41419-019-2180-2
  • Wu DM, Wen X, Han XR, et al. Role of circular RNA DLEU2 in human acute myeloid leukemia. Mol Cell Biol 2018;38(20). e0037522.
  • Wang N, Yang B, Jin J, et al. Circular RNA circ_0040823 inhibits the proliferation of acute myeloid leukemia cells and induces apoptosis by regulating miR-516b/PTEN. J Gene Med. 2022;24(3):e3404.
  • Riva L, Luzi L, Pelicci PG. Genomics of acute myeloid leukemia: the next generation. Front Oncol. 2012;2:40.
  • Tabe Y, Konopleva M. Role of microenvironment in resistance to therapy in AML. Curr Hematol Malig Rep. 2015;10(2):96–103. DOI:10.1007/s11899-015-0253-6
  • Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25(11):1315–1321. DOI:10.1038/nbt1350
  • Sun YM, Wang WT, Zeng ZC, et al. circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression. Blood. 2019;134(18):1533–1546.
  • Wang X, Jin P, Zhang Y, et al. CircSPI1 acts as an oncogene in acute myeloid leukemia through antagonizing SPI1 and interacting with microRNAs. Cell Death Dis. 2021;12(4):297. DOI:10.1038/s41419-021-03566-2
  • Lin L, Wang Y, Bian S, et al. A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia. J Transl Med. 2021;19(1):123. DOI:10.1186/1479-5876-12-123
  • Zhang H, Shen Z, Zhou Y, et al. Downregulation of miR-654-3p in colorectal cancer indicates poor prognosis and promotes cell proliferation and invasion by targeting SRC. Front Genet. 2020;11:577948.
  • Xiong J, Xing S, Dong Z, et al. Yang P: miR-654-3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non-small-cell lung cancer. Mol Med Rep. 2021;23(2):124.
  • Cui X, Yang Y, Yan A. MiR-654-3p constrains proliferation, invasion, and migration of sinonasal squamous cell carcinoma via CREB1/PSEN1 regulatory axis. Front Genet. 2021;12:799933.
  • Hu Q, Gu Y, Chen S, et al. Hsa_circ_0079480 promotes tumor progression in acute myeloid leukemia via miR-654-3p/HDGF axis. Aging (Albany NY). 2020;13(1):1120–1131.
  • UniProt C. UniProt: a worldwide hub of protein knowledge. Nucl Acid Res. 2019;47(D1):D506–D515.
  • Zhang B, Sun YF, Zhang XM, et al. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis. Eur Rev Med Pharmacol Sci. 2020;24(9):4940–4953.
  • Amos-Landgraf J, Franklin C, Godfrey V, et al. The mutant mouse resource and research center (MMRRC): the NIH-supported national public repository and distribution archive of mutant mouse models in the USA. Mamm Genome. 2021;33(1):203–212.